Mainz Biomed
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 |
|---|---|---|
Revenue | $373 | $520 |
Gross Profit | 255 | 319 |
EBITDA | -10,087 | -9,471 |
EBIT | -10,768 | -9,807 |
Net Income | -10,626 | -11,023 |
Net Change In Cash | 373 | 520 |
Free Cash Flow | -9,079 | -8,265 |
Cash | 6,235 | 977 |
Basic Shares | 968 | 558 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $893 | $895 | $529 | $577 |
Gross Profit | 574 | 509 | 182 | 177 |
EBITDA | -19,558 | -25,011 | -25,718 | -11,281 |
EBIT | -20,575 | -26,045 | -26,177 | -11,350 |
Net Income | -21,650 | -26,295 | -26,452 | -11,690 |
Net Change In Cash | 893 | 895 | 529 | 577 |
Free Cash Flow | -17,344 | -23,837 | -15,428 | -3,237 |
Cash | 6,235 | 7,070 | 17,141 | 8,727 |
Basic Shares | 968 | 16,242 | 14,157 | 7,210 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0 |
2025-03-31 | -$7.71 |
2024-12-31 | -$7.71 |
